Patient Initial Size Follow-up size Chemo therapy Primary Cancer Further follow-up studies and metastatic disease status
1 3 7 yes prostate 3yrs follow-up showed waxing and waning nodules.
Metastatic disease to bone and lymph nodes
2 6 8 yes esophagus 3yrs follow-up showed stable nodules.
Patient was disease free
3 2 7 yes Breast 3yrs follow-up showed progressive increased size of nodules.
Metastatic disease to bone and chest wall.
4 4 7 No Colon 5yrs follow-up showed increased size of nodules.
Metastatic disease to liver and peritoneum.
4 5 23 No Colon  
5 9 15 No Breast 4yrs follow-up showed stable nodules.
Biopsy of nodules grew MAIC.
6 4 6 yes colon 3yrs follow-up showed increased size of nodules.
Metastatic disease to liver, lymph nodes and peritoneum.
7 3 20 yes colon 3yrs follow-up showed increased size and number of nodules.
Metastatic disease to liver
8 1 5 No Breast 2yrs follow-up showed increased size of nodules.
Metastatic disease to liver, bone and lymph nodes.
9 2 7 yes colon 2yrs follow-up showed progressive increased size of nodules.
Metastatic disease to liver and bone
10 2 6 yes esophagus 4yrs follow-up showed waxing and waning nodules.
Metastatic disease to liver
Table 4: Nodule missed by NBH CT which grew.